A clinical trial to compare ipatasertib plus atezolizumab and paclitaxel versus a placebo plus different combinations of ipatasertib, atezolizumab and paclitaxel in people with triple-negative breast cancer.

A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer